Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
Watanabe, Masaru; Kenmotsu, Hirotsugu; Ko, Ryo; Wakuda, Kazushige; Ono, Akira; Imai, Hisao; Taira, Tetsuhiko; Naito, Tateaki; Murakami, Haruyasu; Abe, Masato; Endo, Masahiro; Nakajima, Takashi; Koh, Yasuhiro; Takahashi, Toshiaki.
; 109(8): 2539-2548, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29900633
Single tube liquid biopsy for advanced non-small cell lung cancer.
Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level.
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression.
ALK alterations and inhibition in lung cancer.
Does TMB Impact the Effectiveness of TKIs in <i>EGFR</i>-Mutant NSCLC?
Genomic landscape of non-small cell lung cancer in smokers and never-smokers.
Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients.